Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
United Therapeutics Corporation company logo
United Therapeutics Corporation logo

United Therapeutics Corporation (UTHR)

Summary

As of today, UTHR price is $527.20, up +1.58% in the most recent trading session on
UTHR price is currently -13.48% below its historical high of $609.35 set on
UTHR current market cap is $26B, up +92.02% over the past 365 days
UTHR current PE ratio is 19.46
UTHR current annual revenue is $3.18B, up +10.61% year-over-year
As of today, the next earnings release for UTHR has not been scheduled

Profile

Company profile for United Therapeutics Corporation (UTHR)
MetricValue
Full NameUnited Therapeutics Corporation
TickerNASDAQ: UTHR
ExchangeNASDAQ
SectorHealthcare
IndustrySpecialty & Generic Drug Manufacturers
CountryUnited States
IPO
IndexesNot included
Websiteunither.com
Employees1,305

Key Metrics

United Therapeutics Corporation Key Details
MetricValueDate
Price$527.20
Price, 1D Change+1.58%
Market Cap$26B
-
PE Ratio19.46
Beta0.10
Revenue$3.18B
Revenue, 1Y Change+10.61%
EPS$27.86
EPS, 1Y Change+13.08%

Chart

SUGGESTED SERIES
United Therapeutics Corporation chart

Events

United Therapeutics Corporation Events
MetricValueDate
Next EarningsN/A
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last Split2:1
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

UTHR Estimates
MetricValueDate
EPS$27.86
EPS Estimate$26.92N/A
EPS Est. Change-3.39%N/A
Revenue$3.18B
Revenue Estimate$3.24BN/A
Revenue Est. Change+1.67%N/A
Current Price$527.20
Price Target$687.00-
Price Tgt. Change+30.31%-

🔒 Log In To Unlock Full Data

EPS

UTHR EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
$24.57$24.64+0.30%
$26.95$27.86+3.41%
$26.92N/A-3.39%
$31.51N/A+13.09%
UTHR EPS reported versus estimate values chart

Revenue

UTHR revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$2.88B$2.88B+0.08%
$3.20B$3.18B-0.55%
$3.24BN/A+1.67%
$3.68BN/A+15.63%
UTHR revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

UTHR Performance
MetricValueDate
Price, 1Y+74.33%
Price, 3Y+123.04%
Market Cap, 1Y+92.02%
Market Cap, 3Y+136.77%
Revenue, 1Y+10.61%
Revenue, 3Y+64.37%
EPS, 1Y+13.08%
EPS, 3Y+85.81%

🔒 Log In To Unlock Full Data

Technicals

UTHR Technical Indicators
MetricValueDate
Current Price$527.20
SMA 200$515.67
SMA 50$541.50
EMA 200$506.17
EMA 50$538.42
MACD-$7.22
Beta0.10
ATR$13.18
14-Day RSI38.54
10-Day Volatility9.83%

Dividends

UTHR Dividends
MetricValueDate
-N/A
UpcomingN/AN/A
-
-
$0.00
0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

UTHR Income & Profitability
MetricValueDate
Revenue$3.18B
EPS$27.86
Gross Profit$0.00
Gross Margin87.92%
Operating Income$1.52B
Operating Margin47.67%
Net Income$1.33B
Net Margin41.94%
EBITDA$1.60B

🔒 Log In To Unlock Full Data

Financial Health

UTHR Financial Health
MetricValueDate
Debt To Equity0.00
6.60
6.28
-
5
21.05

Valuations

UTHR Valuations
MetricValueDate
PE Ratio19.46
8.28
4.45
15.58
-N/A

Balance Sheet

UTHR Balance Sheet
MetricValueDate
Book Value$7.10B
$2.92B
$7.97B
$3.70B
$872.90M
$560.60M
Total Debt$0.00
$0.00
$7.10M

Expenses

UTHR Expenses
MetricValueDate
$1.85B
$1.28B
$384.40M
$0.00
$85.60M
$0.00
$379.20M

Cash Flow

UTHR Cash Flow
MetricValueDate
$1.56B
-$551.30M
-$1.15B
Capex$526.00M
$1.04B

Recent analyst updates

UTHR Recent analyst updates
MetricValueDate
JP Morgan→
B of A Securities→
RBC Capital→
Wells Fargo→
RBC Capital→
Morgan Stanley→
Wells Fargo→
HC Wainwright & Co.→
B of A Securities→
TD Cowen→

Analyst sentiment

Sentiment over the past month
UTHR analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
UTHR institutional ownership distribution chart

Screeners with UTHR

FAQ

What is the ticker symbol for United Therapeutics Corporation?
The ticker symbol for United Therapeutics Corporation is NASDAQ:UTHR
Does United Therapeutics Corporation pay dividends?
No, United Therapeutics Corporation does not pay dividends
What sector is United Therapeutics Corporation in?
United Therapeutics Corporation is in the Healthcare sector
What industry is United Therapeutics Corporation in?
United Therapeutics Corporation is in the Specialty & Generic Drug Manufacturers industry
What country is United Therapeutics Corporation based in?
United Therapeutics Corporation is headquartered in United States
When did United Therapeutics Corporation go public?
United Therapeutics Corporation initial public offering (IPO) was on June 17, 1999
Is United Therapeutics Corporation in the S&P 500?
No, United Therapeutics Corporation is not included in the S&P 500 index
Is United Therapeutics Corporation in the NASDAQ 100?
No, United Therapeutics Corporation is not included in the NASDAQ 100 index
Is United Therapeutics Corporation in the Dow Jones?
No, United Therapeutics Corporation is not included in the Dow Jones index
When was United Therapeutics Corporation last earnings report?
United Therapeutics Corporation's most recent earnings report was on August 5, 2026
When does United Therapeutics Corporation report earnings?
The date for United Therapeutics Corporation's next earnings report has not been announced yet

Data Sources & References

  1. UTHR Official Website www.unither.com
  2. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1082554/000108255426000006/0001082554-26-000006-index.htm
  3. UTHR Profile on Yahoo Finance finance.yahoo.com/quote/UTHR
  4. UTHR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/uthr